Results 301 to 310 of about 542,281 (388)

Hansen Solubility Parameter Guided Development of Furan‐2,5‐Dicarboxylate Plasticizers for Poly(3‐Hydroxybutyrate‐co‐3‐Hydroxyhexanoate)

open access: yesJournal of Applied Polymer Science, EarlyView.
Compatible plasticizers derived from furan‐2,5‐dicarboxylic acid were identified using Hansen solubility parameters for poly(3‐hydroxybutyrate‐co‐3‐hydroxyhexanoate) (PHB‐co‐HHx). These plasticizers were synthesized and blended with PHB‐co‐HHx to analyze their effects on the thermal and mechanical performance compared to diethyl phthalate at various ...
Kush G. Patel   +7 more
wiley   +1 more source

Reactive Oligomeric Compatibilizers: Chain Length and Additive Effects on PLA/PBAT Phase Interaction

open access: yesJournal of Applied Polymer Science, EarlyView.
This study explores the development of tailored compatibilizers made from PLA and PBAT oligomers, enhanced with reactive additives like ESBO and adipic acid. By combining spectroscopic, thermal, and rheological analyses, the work demonstrates how molecular structure and additive selection control the phase behavior and mechanical properties of the ...
Lena Marbach   +2 more
wiley   +1 more source

Efficient Removal of Cd(II) and PB(II) Ions Using Innovatively Functionalized Poly(2,5‐Dihydro‐2,5‐Dimethoxyfuran) for Water Treatment Applications

open access: yesJournal of Applied Polymer Science, EarlyView.
Synthesis and surface functionalization of pDHMF for enhanced Cd(II) and Pb(II) adsorption from water. ABSTRACT In this work, a novel polymeric adsorbent was synthesized via the cationic polymerization of cis, trans‐2,5‐dihydro‐2,5‐dimethoxyfuran (DHMF), a renewable monomer derived from biomass. To improve its adsorption performance, synthesized poly(2,
Nuran Erduran   +3 more
wiley   +1 more source

Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

open access: yesArthritis &Rheumatology, EarlyView.
Objective Raynaud phenomenon (RP) is often the initial clinical manifestation of systemic sclerosis (SSc), but some patients develop other manifestations first. To help elucidate the diversity of SSc presentation in its early stages, we describe the initial clinical manifestations and antinuclear antibody (ANA) profiles of patients in two early SSc ...
Iqtidar Hanif   +32 more
wiley   +1 more source

B cells and systemic sclerosis interstitial lung disease

open access: yesArthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy